Murine interleukin-4 displays potent anti-tumor activity in vivo
- 1 May 1989
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 57 (3), 503-512
- https://doi.org/10.1016/0092-8674(89)90925-2
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Immunotherapy of cancer using interleukin 2: current status and future prospectsImmunology Today, 1988
- Role of interleukin 2, interleukin 4, and alpha, beta, and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity.The Journal of Experimental Medicine, 1988
- Platelet-activating factor and cellular immune responsesImmunology Today, 1987
- Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells.The Journal of Experimental Medicine, 1987
- Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal developmentCell, 1986
- Tumor Necrosis Factor (TNF)Science, 1985
- Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 1985
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982
- The beige mutation in the mouse selectively impairs natural killer cell functionNature, 1979
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975